je.st
news
Zacks Investment Research Upgrades Medifast Inc (MED) to Buy
2016-04-12 22:33:55| Biotech - Topix.net
The firm currently has $33.00 target price on the stock. According to Zacks, "Medifast Inc has one operating subsidiary, Jason Pharmaceuticals, Inc, its manufacturing arm.
Tags: buy
research
med
investment
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||